Skip to main content

MoneyWorks4Me

Aarey Drugs & Pharma - Quaterly Results

14 Aug 2023 Evaluate
The sales moved down -57.12% to Rs. 509.56 millions for the June 2023 quarter as compared to Rs. 1188.41 millions during the corresponding quarter last year.The Net proft of the company remain more or less same to Rs. 7.25  millions from Rs. 8.00 millions ,decline by -9.38%.Operating Profit saw a handsome growth to 20.36 millions from 17.55 millions in the quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202306 202206 % Var 202306 202206 % Var 202303 202203 % Var
Sales 509.56 1188.41 -57.12 509.56 1188.41 -57.12 4142.53 4926.80 -15.92
Other Income 6.97 8.54 -18.38 6.97 8.54 -18.38 74.33 27.48 170.49
PBIDT 20.36 17.55 16.01 20.36 17.55 16.01 104.57 140.15 -25.39
Interest 8.95 5.48 63.32 8.95 5.48 63.32 28.67 19.88 44.22
PBDT 11.41 12.07 -5.47 11.41 12.07 -5.47 75.90 120.27 -36.89
Depreciation 4.16 4.07 2.21 4.16 4.07 2.21 15.74 20.00 -21.30
PBT 7.25 8.00 -9.38 7.25 8.00 -9.38 60.16 100.27 -40.00
TAX 0.00 0.00 0.00 0.00 0.00 0.00 22.39 34.82 -35.70
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -0.40 -1.08 -62.96
PAT 7.25 8.00 -9.38 7.25 8.00 -9.38 37.77 65.45 -42.29
Equity 253.84 253.84 0.00 253.84 253.84 0.00 253.85 253.85 0.00
PBIDTM(%) 4.00 1.48 170.56 4.00 1.48 170.56 2.52 2.84 -11.26
Peers
Company Name CMP
Redington 327.50
Adani Enterprises 2735.00
Amrapali Industries 33.57
Maxgrow India 172.35
Rashi Peripheral 738.20
View more..